This topic contains a solution. Click here to go to the answer

Author Question: How does a frequent-user incentive differ from a premium?[br][br][b][color=#151B54]Question ... (Read 26 times)

jenna1

  • Hero Member
  • *****
  • Posts: 568
How does a frequent-user incentive differ from a premium?

Question 2

When a manufacturer like ExxonMobil refines crude oil, that corporation is using a(n) ____ process.
 A) analytical
  B) extraction
  C) manufacturing
  D) refining
  E) synthetic



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

scrocafella

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A frequent-user incentive is a program developed to reward customers who engage in repeat or frequent purchases, whereas a premium is a gift offered for buying a product whether or not the customer is a repeat or frequent purchaser.

Answer to Question 2

A




jenna1

  • Member
  • Posts: 568
Reply 2 on: Jul 14, 2018
Great answer, keep it coming :)


jordangronback

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library